Integer

Integer Schedules First Quarter 2024 Earnings Release and Conference Call for April 25, 2024

Retrieved on: 
Thursday, March 28, 2024

PLANO, Texas, March 28, 2024 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR) announced today that it plans to release financial and operational results for first quarter 2024, at 7 a.m. Central Time (CT) / 8 a.m. Eastern Time (ET) on Thursday, April 25, 2024.

Key Points: 
  • PLANO, Texas, March 28, 2024 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR) announced today that it plans to release financial and operational results for first quarter 2024, at 7 a.m. Central Time (CT) / 8 a.m. Eastern Time (ET) on Thursday, April 25, 2024.
  • Following the release, Integer management will host a webcast at 8 a.m. CT / 9 a.m.
  • The conference call will also be available live or via archived replay on the Investor Relations section of the Integer website at: investor.integer.net .
  • To automatically receive Integer financial news by email, please visit investor.integer.net and subscribe to email alerts.

Integer Holdings Corporation Reports Results for Fourth Quarter and Full Year 2023

Retrieved on: 
Thursday, February 15, 2024

PLANO, Texas, Feb. 15, 2024 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR), a leading medical device outsource manufacturer, today announced results for the three and twelve months ended December 31, 2023. Unless otherwise stated, all results and comparisons are from continuing operations.

Key Points: 
  • PLANO, Texas, Feb. 15, 2024 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR), a leading medical device outsource manufacturer, today announced results for the three and twelve months ended December 31, 2023.
  • Fourth Quarter 2023 Financial Results (compared to fourth quarter 2022, except as noted)
    Sales increased 11% to $413 million.
  • Cardiac Rhythm Management & Neuromodulation sales increased 7% in the fourth quarter 2023 compared to fourth quarter 2022, with double-digit growth in Neuromodulation, driven by strong demand from emerging customers with PMA (pre-market approval) products.
  • Electrochem sales decreased 42% in the fourth quarter 2023 compared to fourth quarter 2022, returning to a normalized run-rate after previously higher sales from the supply chain recovery.

Integer to Showcase Recently Acquired Capabilities and New Technologies at MD&M West 2024

Retrieved on: 
Thursday, February 1, 2024

PLANO, Texas, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR), a leader in medical device outsource manufacturing, will join innovators and industry leaders around the world in exhibiting at MD&M West, Feb. 6-8, 2024, at the Anaheim Convention Center in Anaheim, California.

Key Points: 
  • Integer’s exhibit will spotlight the recent strategic acquisitions of InNeuroCo and Pulse Technologies, each of which have further enhanced Integer’s capability spectrum in the medical device sector.
  • The acquisition of InNeuroCo brings specific expertise in neurovascular solutions and advanced catheter technologies, while the combination with Pulse Technologies enhances capabilities in precision micro machining, backed by proprietary technologies and a focus on high-growth medical markets.
  • Cardio and Vascular Solutions: A full range of electrophysiology, structural heart, and neurovascular product solutions including high-performing guidewires, steerable introducers and sheaths, therapy delivery systems, and implant technologies.
  • In addition to Integer’s exhibit at booth #1439, MD&M West 2024 attendees can also visit Pulse Technologies at booth #2844 to learn more about complex micro machining for critical medical device components.

Integer to Showcase Latest Innovations in Neuromodulation Miniaturization During NANS 2024 Annual Meeting

Retrieved on: 
Tuesday, January 16, 2024

PLANO, Texas, Jan. 16, 2024 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR), a leading medical device outsource (MDO) manufacturer, will join medtech leaders and innovators around the world in exhibiting at the North American Neuromodulation Society (NANS) Annual Meeting at Caesars Palace in Las Vegas from Jan. 18 – 21, 2024.

Key Points: 
  • PLANO, Texas, Jan. 16, 2024 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR), a leading medical device outsource (MDO) manufacturer, will join medtech leaders and innovators around the world in exhibiting at the North American Neuromodulation Society (NANS) Annual Meeting at Caesars Palace in Las Vegas from Jan. 18 – 21, 2024.
  • During NANS, attendees are invited to visit booth #127 to learn more about Integer’s latest innovations and expanded capabilities in neuromodulation to enable the next generation of miniaturized active implantable devices.
  • “Through miniaturization, Integer is creating the next generation of differentiated platform technologies to accelerate and de-risk OEMs’ path to market for novel implantable medical devices,” said Jim Stephens, President, CRM&N.
  • Xcellion Gen 3 FC delivers best in class battery runtime and full re-charges in as little as 30 minutes.

Integer Holdings Corporation Announces Preliminary Unaudited Sales Results and Acquisition of Pulse Technologies

Retrieved on: 
Wednesday, January 10, 2024

PLANO, Texas, Jan. 10, 2024 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR), a leading medical device outsource manufacturer, today announced fourth quarter 2023 preliminary unaudited sales are expected to be in the range of $411 million to $413 million, an increase of 10% to 11% compared to fourth quarter 2022. Preliminary unaudited full year 2023 sales are expected to be in the range of $1.595 billion to $1.597 billion, an increase of 16% compared to full year 2022.

Key Points: 
  • Based in Quakertown, Pennsylvania, Pulse Technologies also provides proprietary advanced technologies, including Hierarchical Surface Restructuring (HSR™), Scratch-Free Surface Finishes, and Titanium Nitride Coatings.
  • “The acquisition of Pulse Technologies is directly aligned with Integer’s strategy to expand our capabilities and capacity in targeted growth markets,” said Payman Khales, Integer President, Cardio & Vascular.
  • “We were immediately impressed with Pulse Technologies’ long-standing customer relationships, technical talent, unique technologies, shared values, and capacity for growth.
  • Pulse Technologies’ estimated full year 2023 sales are approximately $42 million with 2023 adjusted EBITDA(a) expected to be approximately $11 million.

Integer to Participate in Piper Sandler 35th Annual Healthcare Conference

Retrieved on: 
Thursday, November 16, 2023

PLANO, Texas, Nov. 16, 2023 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR) today announced participation in the upcoming Piper Sandler 35th Annual Healthcare Conference to be held in New York City from Nov. 28–30, 2023.

Key Points: 
  • PLANO, Texas, Nov. 16, 2023 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR) today announced participation in the upcoming Piper Sandler 35th Annual Healthcare Conference to be held in New York City from Nov. 28–30, 2023.
  • Joseph Dziedzic, President and Chief Executive Officer, is scheduled to present on Wednesday, Nov. 29, 2023, at 10:00 a.m. EST.
  • The link to the live webcast may also be accessed under “News & Events” on the Investor Relations section of the Integer website at investor.integer.net .
  • A replay of the webcast will be available on the company’s website for approximately three months.

Integer to Showcase European Expansion, Commitment to Medical Device OEMs and Start-Ups at Compamed 2023

Retrieved on: 
Wednesday, November 8, 2023

PLANO, Texas, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR), a leading medical device outsource (MDO) manufacturer and a complete partner in innovation, will exhibit at Compamed 2023 from November 13-16, in Düsseldorf, Germany.

Key Points: 
  • PLANO, Texas, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR), a leading medical device outsource (MDO) manufacturer and a complete partner in innovation, will exhibit at Compamed 2023 from November 13-16, in Düsseldorf, Germany.
  • During Compamed, Integer looks forward to connecting with medical device OEMs and start-ups to discuss its comprehensive suite of solutions from prototype to pilot and beyond.
  • Integer’s focal points for Compamed 2023 revolve around the company’s significant investments in Europe, particularly in Ireland.
  • Alongside the New Ross expansion, Integer has also invested in a new R&D and manufacturing facility in Galway, Ireland.

Practice Panda Brings Integrated Digital Services Approach to Tax & Accounting Space

Retrieved on: 
Tuesday, October 17, 2023

MINNEAPOLIS, Oct. 17, 2023 /PRNewswire/ -- Tax and accounting professionals now have a new partner to help them showcase their expertise to clients and to help navigate the daily challenges of running a professional practice.

Key Points: 
  • Mostad Marketing Cloud, Integer, and TaxVid, three leading solutions of digital services for tax and accounting professionals from Client Centric Communications, Inc., announced today that they are rebranding and merging into one solution called Practice Panda.
  • This internal merger brings together years of expertise in marketing, website development, and video content creation specifically for tax and accounting firms.
  • Together as Practice Panda, they will offer tax and accounting professionals a comprehensive digital services platform from one location.
  • Our commitment is to help tax and accounting professionals save time by providing practice management tools and client-centric content, which will free up more time to focus on essential client services."

Integer to Exhibit at 2023 MD&M Minneapolis Expo, Oct. 10 – 11

Retrieved on: 
Friday, October 6, 2023

PLANO, Texas, Oct. 06, 2023 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR), a leading medical device outsource (MDO) manufacturer, will join medtech industry leaders and innovators around the world in exhibiting at the MD&M Minneapolis Exposition from Oct. 10 – 11, 2023, at the Minneapolis Convention Center.

Key Points: 
  • PLANO, Texas, Oct. 06, 2023 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR), a leading medical device outsource (MDO) manufacturer, will join medtech industry leaders and innovators around the world in exhibiting at the MD&M Minneapolis Exposition from Oct. 10 – 11, 2023, at the Minneapolis Convention Center.
  • Attendees are invited to visit Integer at booth #3011 to learn more about Integer’s range of innovative end-to-end medical device design, development and manufacturing solutions.
  • At the Expo, Integer will be specifically highlighting new advances in miniaturization for implantable battery technology.
  • This extends to a new micro-coin cell form factor supporting miniaturization for novel therapeutic and diagnostic devices.

Practice Panda Brings Integrated Digital Services Approach to Tax & Accounting Space

Retrieved on: 
Tuesday, October 17, 2023

MINNEAPOLIS, Oct. 16, 2023 /PRNewswire/ -- Tax and accounting professionals now have a new partner to help them showcase their expertise to clients and to help navigate the daily challenges of running a professional practice.

Key Points: 
  • Mostad Marketing Cloud, Integer, and TaxVid, three leading solutions of digital services for tax and accounting professionals from Client Centric Communications, Inc., announced today that they are rebranding and merging into one solution called Practice Panda.
  • This internal merger brings together years of expertise in marketing, website development, and video content creation specifically for tax and accounting firms.
  • Mostad Marketing Cloud, Integer, and TaxVid, three leading solutions of digital services for tax and accounting professionals from Client Centric Communications, Inc., announced today that they are rebranding and merging into one solution called Practice Panda.
  • Together as Practice Panda, they will offer tax and accounting professionals a comprehensive digital services platform from one location.